| Patient | Thomas Jefferson |
|---|---|
| Date of birth | 1979-04-13 |
| Identifiers | MRN HR-EN005-SYN; SSN (made up) 000-05-2276 |
| Document date | 2026-06-18 |
| Author | Nathaniel Beaumont-Ruiz, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-week review, four weeks after starting propranolol. [S]
Mr. Jefferson returns four weeks after starting propranolol 80 mg each evening. He felt a little tired in the first week, and that has passed; he has had no dizziness, wheeze or breathlessness on his walks. His diary shows 4 migraine days in the past four weeks, each treated with sumatriptan and naproxen; he was pain-free within two hours in three of the four attacks and back at work by midday. He used no other acute medicine, so his acute-medicine days total 4. The cold he had ten days ago has gone. His diary is missing three days during the cold. He has not yet seen the occupational therapist because of a waiting list, and writing remains slow; he has started using dictation for long reports. [S]
| Element | Detail |
|---|---|
| Propranolol | 80 mg each evening for four weeks; tiredness in the first week only |
| Migraine days | 4 in the past four weeks, from 13 before prevention |
| Acute medicine | Sumatriptan with naproxen on 4 days; pain-free at two hours in 3 of 4 |
| Cold | Resolved |
| Occupational therapy | Not yet seen; waiting list |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Tiredness of the first week has passed |
| Respiratory | Negative | No wheeze or breathlessness |
| Neurological | Positive | Four migraine attacks in four weeks; no new features |
| Musculoskeletal | Positive | Right wrist stiff and sore after long writing |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen 500 mg oral tablet, one tablet with food at the start of a headache, may repeat once after 12 hours; no more than two days a week | One tablet at headache onset, may repeat once after 12 hours; no more than two days a week | Oral route | 2026-05-07 | active | S |
| Metoclopramide 10 mg oral tablet, one tablet with the naproxen when a headache brings nausea; no more than two days a week | One tablet with the acute medicine when nausea is present, no more than once a day | Oral route | 2026-05-07 | active | S |
| Sumatriptan 100 mg oral tablet, one tablet with naproxen early in a migraine attack, may repeat once after 2 hours; no more than two tablets a day and no more than nine days a month | One tablet at attack onset with naproxen, may repeat once after 2 hours; up to 200 mg a day | Oral route | 2026-05-21 | active | S |
| Propranolol extended-release 80 mg oral capsule, one capsule each evening, for migraine prevention | One capsule each evening | Oral route | 2026-05-21 to 2026-06-18 | completed | S |
| Propranolol extended-release 120 mg oral capsule, one capsule each evening, for migraine prevention | One capsule each evening | Oral route | 2026-06-18 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-18 | Body height | 189 | cm | S |
| 2026-06-18 | Body weight | 76 | kg | S |
| 2026-06-18 | Body mass index (BMI) [Ratio] | 21.3 | kg/m2 | S |
| 2026-06-18 | Systolic blood pressure | 116 | mm[Hg] | S |
| 2026-06-18 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-06-18 | Heart rate | 60 | /min | S |
| 2026-06-18 | Respiratory rate | 14 | /min | S |
| 2026-06-18 | Body temperature | 36.6 | Cel | S |
| 2026-06-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Vital signs recorded on 2026-06-18; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 116/74, pulse 60 |
| Neurological | Normal |
| Musculoskeletal | Right wrist with reduced flexion and extension and a prominent ulnar head; finger joints swollen; grip weaker on the right |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Recurrent disabling headaches since early adulthood, in bouts lasting days to weeks, now in the seventh day of a bout; under evaluation, with a two-week headache diary and a headache medicine consultation; no red flags | resolved | confirmed | R51.9 | S — Synthetic presenting problem anchored to his documented periodical headaches; superseded when the consultation confirmed migraine without aura. |
| Migraine without aura, episodic, with bouts of near-daily attacks lasting two to three weeks; ICHD-3 criteria met in a two-week diary; synthetic modern diagnosis linked to his documented periodical headaches, which historians have usually but not unanimously called migraine | active | confirmed | G43.009 | S — Synthetic modern diagnosis made at the consultation; the historical diagnosis is disputed (CLM-0013), so this is not a claim about his real diagnosis. |
| Stiffness and weakness of the right wrist and hand after a dislocation that healed out of place in early middle age; writing is slow and painful after about an hour | active | confirmed | M25.631 | S — Synthetic modern coding of the documented badly healed right wrist dislocation. |
| Common cold with nasal congestion and facial pressure, without bacterial sinusitis, early in propranolol prevention; resolved | resolved | confirmed | J00 | S — Synthetic acute illness; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Red-flag screen (SNNOOP10): systemic signs, neurological signs, sudden or new pattern, onset after 50, positional or Valsalva features, papilledema, progressive course | Every visit | Completed today | No red flags |
| Survey | Headache diary: headache and migraine days, attack features, triggers | Every visit | Completed today | 4 migraine days in four weeks; three days missing during the cold |
| Medication safety | Acute-medicine days (medication overuse headache limits: triptan fewer than 10, NSAID fewer than 15 days a month) | Every visit | Completed today | Acute medicine on 4 days in four weeks |
| Medication safety | Acute treatment response (pain-free at two hours, return to work) | Every visit | Completed today | Pain-free at two hours in 3 of 4 attacks with sumatriptan and naproxen |
| Medication safety | Propranolol tolerability: pulse, blood pressure, tiredness, exercise tolerance, wheeze, cold hands, sleep | Four weeks after starting or changing the dose, then each visit | Completed today | Pulse 60, blood pressure 116/74; tiredness in the first week only; no wheeze; dose raised to 120 mg |
| Examination | Preventive efficacy (at least 50% fewer migraine days) | At two to three months on an adequate dose | Due | Four weeks on 80 mg; efficacy judged at the three-month review |
| Survey | Disability (MIDAS, recorded as its five items, and HIT-6) | At baseline and after about three months of prevention | Up to date | Repeat at three months |
| Survey | Mood (PHQ-9) and anxiety (GAD-7), including on a beta-blocker | At baseline, four to six weeks after starting a preventive that can affect mood, then at each review | Deferred | The PHQ-9 planned four to six weeks after starting propranolol was not repeated today. No harm is evident: he reports a steady mood and no low mood or loss of interest on direct questions. Corrective action: PHQ-2 at the preventive visit and PHQ-9 and GAD-7 at the three-month review |
| Imaging | Neuroimaging | Only for red flags or a change in pattern | Not indicated | No red flags or change in pattern |
| Self-management | Sleep, meals, caffeine and work-stress plan | Every visit | Completed today | Fixed wake time and regular lunch kept; walks most days |
| Referral | Occupational therapy visit for the right wrist and writing | Within four weeks of intake | Deferred | Not seen four weeks after intake because of a waiting list. No harm so far beyond continued slow writing, eased by dictation. Corrective action: the clinic booked a hand therapist with an earlier opening |
Goal progress:
Guideline basis: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018); The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update (2024); The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice (2019); Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025); Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025); Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)
Follow-up: Preventive visit in four weeks. Three-month review in eight weeks. Diary continued. Next scheduled visit 2026-07-16: periodic adult preventive visit. [S]